In this episode of Sue Wall Street: Holding Wall Street Accountable, we examine the securities class action lawsuit involving Phreesia ($PHR). We break down allegations that the healthcare technology company overstated visibility into future growth, pharmaceutical marketing demand, and the strength of its Network Solutions business before lowering fiscal 2027 revenue guidance. Investors, shareholders, healthcare IT followers, and growth stock enthusiasts will gain insight into guidance cuts, revenue forecasting, customer spending trends, analyst reactions, and the securities law claims at the center of this case.

Visit ZLK.com for more info.

Add our WhatsApp Channel

We’re not lawyers or accountants, so don’t take this as legal or financial advice.